Clinico-pathologic Evaluation of Patients with Hemangioendothelioma: A 10-year Experience from Shiraz, Southern of Iran
Abstract
Background: Hemangioendothelioma (HE) represents a group of rare, borderline malignant vascular tumors with diverse clinical presentations and diagnostic challenges. This study aims to investigate the demographic, clinical, radiological data, histological findings, treatment modalities, survival rates, and other key characteristics of HE cases in both pediatric and adult patients. Materials and Methods: This is a case series cross-sectional study conducted at Namazi Teaching Hospital and Abuali Sina Hospital, Shiraz University of Medical Sciences. The study involved a retrospective review of medical records from 2009 to 2019, focusing on 22 patients diagnosed with HE. Data were collected using a standardized collection form. For precise histological examination, tissue slides were extracted and analyzed, incorporating pathological variables and immunohistochemical markers. Results: In this study, a total of 22 patients diagnosed with HE was examined. Their mean age was 40.6 years with male-to-female ratio of 12:10. The majority of cases in this study were diagnosed with hepatic epithelioid HE (59%). The most commonly reported symptoms included abdominal pain and palpable masses. Radiologically, the tumors primarily appeared as hypo-dense lesions, often accompanied by peripheral rim enhancement. Pathologically, the features such as intracytoplasmic vacuolization, eosinophilic cytoplasm, and specific markers (CD31, CD34) were crucial in accurate diagnosis. Importantly, the study also revealed a positive outcome in terms of patient survival, with only 10% of surgically treated patients succumbing to the disease. Conclusion: This study provides a detailed clinico-pathologic evaluation of HE from Southern Iran, underscoring the critical relationship between tumor location and clinical presentation. The research highlights that HE, though rare, can occur in pediatric and adults and must be included in the differential diagnosis of vascular lesions across all age groups. From a therapeutic perspective, surgical intervention emerged as the most effective treatment modality, associated with a notably high survival rate of 90% among operated patients.
References
Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol. 2013; 30(1): 29-44.
https://doi.org/10.1053/j.semdp.2012.01.003
PMid:23327728
Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982; 50(5): 970-81.
https://doi.org/10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z
PMid:7093931
Stacchiotti S, Miah A, Frezza A, Messiou C, Morosi C, Caraceni A, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO open. 2021; 6(3): 100170.
https://doi.org/10.1016/j.esmoop.2021.100170
PMid:34090171 PMCid:PMC8182432
Rosenberg A, Agulnik M. Epithelioid hemangioendothelioma: update on diagnosis and treatment. Curr Treat Options Oncol. 2018; 19(4): 1-8.
https://doi.org/10.1007/s11864-018-0536-y
PMid:29546487
Guo Q, Xue J, Xu L, Shi Z, Zhou B. The clinical features of epithelioid hemangioendothelioma in a Han Chinese population: A retrospective analysis. Medicine. 2017; 96(26): e7345.
https://doi.org/10.1097/MD.0000000000007345
PMid:28658152 PMCid:PMC5500074
Li W, Li JK, Zheng X, Chen LL, Yang YH. Clinicopathological features of primary pulmonary epithelioid hemangioendothelioma: a study of 7 cases. Zhonghua Zhong Liu Za Zhi. 2025; 47(3): 269-274.
Deng C, An Y, Liu J, Wang C, Gou H, Zhang J, et al. Hepatic epithelioid hemangioendothelioma, a rare liver tumor: a case report and review of the literature. Front Oncol. 2025; 15: 1522002.
https://doi.org/10.3389/fonc.2025.1522002
PMid:40452839 PMCid:PMC12122502
Mardani P, Shahriarirad R, Nekooeian M, Anbardar MH, Ziaian B, Kamran H, et al. Pleural epithelioid hemangioendothelioma in a 39-Year-old female: a case report. J Cardiothorac Surg. 2024; 19(1): 118.
https://doi.org/10.1186/s13019-024-02602-4
PMid:38475834 PMCid:PMC10935829
Xu J, Hu S, Li S, Wang W, Zhou X, Wu Y, et al. Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review. World J Surg Onc. 2020; 18(1): 1-8.
https://doi.org/10.1186/s12957-020-02034-z
PMid:33121478 PMCid:PMC7596953
Kaur G, Mitra S, Barwad A, Chatterjee D, Dey T, Khosla D, Saikia UN, Kaman L, Dutta U, Duseja A, Das A. Clinical, Histopathological, and Immunophenotypic Spectrum of Hepatic Epithelioid Hemangioendothelioma: Eight Years' Data of a Tertiary Care Center from North India. J Clin Exp Hepatol. 2025; 15(1): 102429.
https://doi.org/10.1016/j.jceh.2024.102429
PMid:39564429 PMCid:PMC11570939
Liu Z, Yi L, Chen J, Li R, Liang K, Chen X, et al. Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma. BMC Med Imaging. 2020; 20: 1-9.
https://doi.org/10.1186/s12880-020-00465-4
PMid:32600273 PMCid:PMC7322860
Shin SH, Koh YS, Song S. Hepatic epithelioid hemangioendothelioma managed with minimally invasive surgery: A case report. World J Clin Cases. 2025; 13(22): 104924.
https://doi.org/10.12998/wjcc.v13.i22.104924
PMid:40771736 PMCid:PMC12188779
Larson EL, Ciftci Y, Jenkins RT, Zhou AL, Ruck JM, Philosophe B. Outcomes of Liver Transplant for Hepatic Epithelioid Hemangioendothelioma. Clin Transplant. 2025; 39(2): e70087.
https://doi.org/10.1111/ctr.70087
PMid:39869081
Shiba S, Imaoka H, Shioji K, Suzuki E, Horiguchi S, Terashima T, et al. Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study. BMC Cancer. 2018; 18(1): 993.
https://doi.org/10.1186/s12885-018-4934-0
PMid:30340559 PMCid:PMC6194639
Epelboym Y, Engelkemier DR, Thomas-Chausse F, Alomari AI, Al-Ibraheemi A, Trenor III CC, et al. Imaging findings in epithelioid hemangioendothelioma. Clin Imaging. 2019; 58: 59-65.
https://doi.org/10.1016/j.clinimag.2019.06.002
PMid:31238187
Kou K, Chen YG, Zhou JP, Sun XD, Sun DW, Li SX, Lv GY. Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy. World J Clin Cases. 2020; 8(18): 3978-3987.
https://doi.org/10.12998/wjcc.v8.i18.3978
PMid:33024754 PMCid:PMC7520791
Jang JK, Thomas R, Braschi-Amirfarzan M, Jagannathan JP. A review of the spectrum of imaging manifestations of epithelioid hemangioendothelioma. Am J Roentgenol. 2020; 215(5): 1290-8.
https://doi.org/10.2214/AJR.20.22876
PMid:32841059
Chu K, Li Z, Tang W, Jiang X. Updated information regarding management of hepatic epithelioid hemangioendothelioma. Intractable Rare Dis Res. 2022; 11(4): 211-4.
https://doi.org/10.5582/irdr.2022.01113
PMid:36457586 PMCid:PMC9709622
Driskill JH, Zheng Y, Wu B-K, Wang L, Cai J, Rakheja D, et al. WWTR1 (TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma. Genes dev. 2021; 35(7-8): 495-511.
https://doi.org/10.1101/gad.348221.120
PMid:33766984 PMCid:PMC8015719
Cournoyer E, Al‐Ibraheemi A, Engel E, Chaudry G, Stapleton S, Adams DM. Clinical characterization and long‐term outcomes in pediatric epithelioid hemangioendothelioma. Pediatr Blood Cancer. 2020; 67(2): e28045.
https://doi.org/10.1002/pbc.28045
PMid:31724797
Sanduzzi-Zamparelli M, Rimola J, Montironi C, Nunes V, Alves VAF, Sapena V, et al. Hepatic epithelioid hemangioendothelioma: an international multicenter study. Dig Liver Dis. 2020; 52(9): 1041-6.
https://doi.org/10.1016/j.dld.2020.05.003
PMid:32535084
Putra J, Gupta A. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis. Pathology. 2017; 49(4): 356-62.
https://doi.org/10.1016/j.pathol.2017.03.001
PMid:28438388
Abdulrahman AA, Yan J, Hou JS. Kaposiform hemangioendothelioma in an adult spleen: An unusual presentation. Hum Pathol: Case Rep. 2017; 10: 15-7.
https://doi.org/10.1016/j.ehpc.2017.04.002
Cao L, Hong J, Zhou L, Ye Y, Liu Y, Yu J, Zheng S. Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience. World J Surg Onc. 2019; 17(1): 1-7.
https://doi.org/10.1186/s12957-019-1729-y
PMid:31699108 PMCid:PMC6839190
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.





